Mandrake Bio
Type
Startup
Founded
2025
Funding captured
$1.7m
Deals captured
1
About Mandrake Bio
Mandrake Bio is a full-stack protein-design company developing molecular machinery for next-generation gene editing. It uses sequence- and structure-aware AI models informed by biological and biophysical requirements, then validates designed proteins through custom assays in its wet lab and partner network. Its applications include tissue-culture-free editing of elite crops and gene editors designed for more accessible genetic medicines.
Mandrake Bio funding captured (1)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Pre-Seed | Jul 16, 2026 | $1.7m |